Korea United Pharm Inc. (033270.KS) KSC

18,100.00

-80(-0.44%)

Updated at June 02 03:30PM

Currency In KRW

Valuation

Market Cap311.49B
Enterprise Value285.22B
P/E Ratio7.27
PEG Ratio0.15
Price/Sales Ratio0.9
Price/Book Ratio0.63
Enterprise/Revenue0.8
Enterprise/EBITDA4.25

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.14
Operating Margin0.16

Management Effectiveness

Return On Assets0.07
Return On Equity0.09

Income Statement

Revenue288.76B
Revenue/Share18,303.92
Gross Profit175.41B
EBITDA60.47B
Net Income38.31B
Diluted EPS2,614.37

Balance Sheet

Total Cash171.65B
Total Cash/Share10,788.23
Total Debt13.32B
Total Debt/Equity0.03
Current Ratio3.36
Book Value Per Share28,895.42

Price History

52-Week Change-13.4
52-Week High22,450
52-Week Low17,770
Moving Average 50 Days19,954.6
Moving Average 200 Days19,638.9

Statistics

Average Volume32,782
Shares Outstanding14.44M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate610
Trailing Annual Dividend Yield3.37
Payout Ratio0.17
Last Split Factor51:50
Last Split DateJanuary 20, 2014